NCT04719533

Brief Summary

To compare short- and long-term outcomes of women following episiotomy during the second stage of labor, following marking of episiotomy location during the first stage of labor with those of women who underwent episiotomy without marking.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 22, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

May 17, 2021

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 24, 2025

Completed
Last Updated

October 21, 2021

Status Verified

October 1, 2021

Enrollment Period

4.4 years

First QC Date

October 2, 2020

Last Update Submit

October 13, 2021

Conditions

Keywords

episiotomyepisiotomy complicationspremarked episiotomy

Outcome Measures

Primary Outcomes (9)

  • Extended laceration of the episiotomy

    Additional perineal tears originating from the original episiotomy, as described in the birth chart

    Up to 1 hour following the episiotomy

  • Third- and fourth-degree perineal tears

    Perineal tears involving the anal sphincter in addition to the episiotomy, as documented in hospital records

    Up to 2 hours following the episiotomy

  • Post-partum hemorrhage

    Early (\<24 hours) or later (24 hours to 6 weeks) hemorrhage following delivery requiring physician intervention as documented in medical records

    Up to 6 weeks following delivery

  • Blood transfusion requirement

    Any requirement for blood products following delivery as documented in the hospital discharge

    Up to 5 days following delivery

  • Episiotomy site infection

    any documented infection of the episiotomy site treated in ambulatory or hospital setting, as recorded in medical records

    Up to 6 weeks following delivery

  • Requirement of resuturing of episiotomy or evacuation of hematoma

    Any additional surgical intervention required relating to the episiotomy, as recorded in medical records

    up to 6 weeks following delivery

  • Long-term symptoms related to episiotomy

    Any symptoms including perineal pain, dyspareunia, urine incontinence or fecal incontinence as reported by women using a numerical scale or dichotomic scale where appropriate

    Up to 5 years following delivery

  • Perineal tears in subsequent deliveries

    As recorded in hospital records

    Up to 5 years following delivery

  • Surgical correction of episiotomy

    Any additional surgical procedures required for correction of episiotomy related symptoms as recorded in medical records

    Up to 5 years following delivery

Study Arms (2)

Pre-marked episiotomy location

EXPERIMENTAL

Women in this group will undergo pre-marking of episiotomy location

Other: Pre-marking of episiotomy location

No pre-marked episiotomy location

NO INTERVENTION

Women in this group will not undergo pre-marking of episiotomy location

Interventions

A template marking the pre-determined correct location of episiotomy will be used to mark to women in the interventional group

Pre-marked episiotomy location

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women 18 years of age or older who present in active labour to our center and consent to participate in the study

You may not qualify if:

  • women under 18 years of age or those who do not or are unable to provide informed consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Soroka University Medical Center

Beersheba, 84101, Israel

RECRUITING

Study Officials

  • Sharon Davidesko, MD

    Soroka University Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sharon Davidesko, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients' data recorded according to a coding system
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: prospective randomized-controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 2, 2020

First Posted

January 22, 2021

Study Start

May 17, 2021

Primary Completion

September 24, 2025

Study Completion

September 24, 2025

Last Updated

October 21, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

No data is to be shared with other researchers

Locations